Health Care & Life Sciences » Biotechnology | Momenta Pharmaceuticals Inc.

Momenta Pharmaceuticals Inc.

Momenta Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
78.31 M
Public Float
46 M
Momenta Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.12
Market Cap
$1.2 B
Shares Outstanding
98.61 M
Public Float
96.65 M

Profile

Address
301 Binney Street
Cambridge Massachusetts 02142
United States
Employees -
Website http://www.momentapharma.com
Updated 07/08/2019
Momenta Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products. It focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune disease. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection.

Financials

View All

Craig A. Wheeler
President, Chief Executive Officer & Director
James R. Sulat
Chairman